Your shopping cart is currently empty

ACHM-025 is a prodrug that is selectively activated by AKR1C3 into a nitrogen mustard DNA alkylating agent. It can be used in cancer research, including studies on leukemia.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | ACHM-025 is a prodrug that is selectively activated by AKR1C3 into a nitrogen mustard DNA alkylating agent. It can be used in cancer research, including studies on leukemia. |
| In vitro | ACHM-025 exhibits potent cytotoxicity specifically in HCT116 cells overexpressing AKR1C3, with an IC50 value of 0.03 μM. |
| In vivo | ACHM-025 (25 mg/kg, administered intraperitoneally on days 0, 7, and 14) significantly reduces the proportion of human leukemia cells in peripheral blood and extends the survival of female NOD/SCID or NSG mice implanted with chemotherapy-resistant T-ALL PDX (ALL-31). |
| Molecular Weight | 544.61 |
| Formula | C17H28N4O10S3 |
| Cas No. | 2377718-85-7 |
| Smiles | O=N(=O)C1=CC=C(C(=C1)S(=O)(=O)N2CCN(C)CC2)N(CCOS(=O)(=O)C)CCOS(=O)(=O)C |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.